The Effect of Pharmacotherapy for Attention Deficit Hyperactivity Disorder on Risk of Seizures in Pediatric Patients as Assessed in an Insurance Claims Database

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|3|2|123-131

ISSN： 1574-8863

Source： Current Drug Safety, Vol.3, Iss.2, 2008-01, pp. : 123-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Adults

By Wilens T.E.   Biederman J.   Spencer T.J.  

CNS Drugs, Vol. 9, Iss. 5, 1998-05 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

By Childress Ann C.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 309-325

Adis International

Access to resources Recommend Favorite

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population

By Christensen Laura   Sasané Rahul   Hodgkins Paul   Harley Carolyn   Tetali Srinivas  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 977-989

Informa Healthcare

Access to resources Recommend Favorite

Attention-Deficit Hyperactivity Disorder: Recent Advances in Paediatric Pharmacotherapy

By May Diane E.   Kratochvil Christopher J.  

Drugs, Vol. 70, Iss. 1, 2010-01 ,pp. : 15-40

Adis International

Access to resources Recommend Favorite

Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder

By Ramos-Quiroga J. Antoni   Casas Miguel  

CNS Drugs, Vol. 25, Iss. 1, 2011-01 ,pp. : 17-36

Adis International

Access to resources Recommend Favorite